175 filings
Page 3 of 9
8-K
ip4alat
11 May 23
Applied Therapeutics Reports First Quarter 2023 Financial Results
7:13am
D
p4zod 1sgk5j
5 May 23
$30.00 mm in equity / options, sold $30.00 mm, 19 investors
4:55pm
8-K
1rrd01tag dbtxel4pc
26 Apr 23
Unregistered Sales of Equity Securities
6:05pm
8-K
78rr47xrc18h9do
24 Apr 23
Entry into a Material Definitive Agreement
8:08am
ARS
7wfejhzo2t67c1b9tt
17 Apr 23
Annual report to shareholders
5:27pm
DEFA14A
f3n1h13sibm zql
17 Apr 23
Additional proxy soliciting materials
4:39pm
8-K
z71 43cmhtsy
14 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
S-8
c7hx b2ui
23 Mar 23
Registration of securities for employees
7:54am
8-K
xi21vx g50ly
23 Mar 23
Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
6:40am
8-K
hex3n
24 Feb 23
Departure of Directors or Certain Officers
4:46pm
8-K
fq5a8rfb 2cgex
4 Jan 23
Entry into a Material Definitive Agreement
5:01pm
8-K
nji4871jz pv09b
18 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
zvip0
9 Nov 22
Applied Therapeutics Reports Third Quarter 2022 Financial Results
7:08am
8-K
gpifkpb
28 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:15pm
DEFA14A
u6ynl g7hc
9 Sep 22
Additional proxy soliciting materials
4:18pm